Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Progesterone boosts alcohol's effect on brain, finasteride counters it.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

Antiandrogen therapy, like cyproterone acetate, effectively treats acne, hirsutism, and hair loss.

Eurycoma longifolia extract may help increase testosterone levels and reduce andropause symptoms.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Phytosterols may help manage prostate issues but are less effective than synthetic drugs.

Anti-androgens help manage PCOS symptoms like excess hair and acne.

Antiandrogens should be used effectively to treat skin conditions like hair loss, acne, and excess hair growth.

Finasteride reduces prostate size and DHT in male mastomys but not in females.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

The (+) enantiomer of YH239-EE effectively kills breast cancer cells.

The compound was successfully made and shows potential for treating prostate cancer.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

Allopregnanolone, a progesterone metabolite, helps reduce restraint effects on behavior.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

5-alpha reductase inhibitors may cause sexual side effects, breast complications, and other health risks in men with hair loss.